January 1, 2019Open Access

Venous thromboembolism prophylaxis in inflammatory bowel disease flare-ups

Key Points

Key points are not available for this paper at this time.

Abstract

Multiple factors were associated with the use of pharmacological prophylaxis in hospitalized patients, including sex, steroid use, history of VTE events or gastrointestinal bleeding, and hematochezia. The incidence of major bleeding was not significantly greater in IBD patients receiving pharmacological prophylaxis.

Read Full Paperexternally

AIに質問

Bookmark

View Full Paper

Cite This Study

Osama Kaddourah (Tue,) studied this question.

synapsesocial.com/papers/695d5135681e9db772643939 https://doi.org/https://doi.org/10.20524/aog.2019.0412

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Venous thromboembolism and underutilisation of anticoagulant thromboprophylaxis in hospitalised patients with inflammatory bowel disease2014 · 28 citations
2Platelets circulate in an activated state in inflammatory bowel disease1994 · 231 citations
3Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients2009 · 23 citations
4European evidence-based Consensus on the management of ulcerative colitis: Current management2008 · 558 citations
5Venous thromboembolism in chronic kidney disease: epidemiology, the role of proteinuria, CKD severity and therapeutics2016 · 29 citations

AIに質問

Bookmark

View Full Paper